Latest Breaking News On - Phase 3 alina study - Page 1 : comparemela.com

The FDA granted priority review to a sBLA seeking the approval of alectinib as adjuvant treatment after surgery for early-stage ALK-positive NSCLC.

Non small cell lung cancerAlk positive non small cell lung cancerPriority reviewPhase 3 alina studyAdjuvant treatment after surgery